Hepatocyte-specific deletion of many known regulators of RIPK1 kinase, such as NEMO, and TAK1, leads to hepatocellular death, steatohepatitis, fibrosis, and hepatocellular carcinoma (HCC)57,58. Here, RIPK1 is linked to hepatocellular carcinoma.